Xenix Medical appears in FDA records as the applicant for a Class II thoracolumbosacral pedicle screw system under 21 CFR 888.3070, product code NKB, in the orthopedic advisory committee. The most recent supplied clearance, K262193, was received June 29, 2026 and decided September 14, 2026 as substantially equivalent, with a summary submitted and no third-party review. An earlier clearance letter, K251154 dated June 12, 2025, names HT Medical d.b.a. Xenix Medical as the applicant for the RIVA Posterior Fixation System and RIVA Posterior Fixation System Navigation Instruments, listing product codes NKB, KWQ and OLO. [1][4][8]
Documented RIVA clearances
K262193 covers the RIVA Posterior Fixation System with NanoACTIV Surface Technology and the RIVA Anchor Sacroiliac Fixation System with NanoACTIV Surface Technology. The FDA record lists the applicant as Xenix Medical at an Orlando, Florida address, with Tyler Holschlag as contact, and classifies the device as a Class II Thoracolumbosacral Pedicle Screw System under regulation 888.3070 and product code NKB. The decision code is SESE, described as substantially equivalent, under a Traditional clearance pathway. [1][8]
The 2025 letter for K251154 identifies the applicant as HT Medical d.b.a. Xenix Medical, with Tyler Holschlag as Vice President Product Development, and covers the RIVA Posterior Fixation System and RIVA Posterior Fixation System Navigation Instruments. That letter states the subject device was found equivalent to cited predicate devices with respect to intended use, indications for use, design, function, materials and performance, and that technological differences did not raise new questions of safety and effectiveness. [4]
Filing scope and navigation instruments
The K262193 documentation describes RIVA Posterior Fixation System Navigation Instruments as intended for use with the Xenix Medical RIVA Anchor Sacroiliac Fixation System during surgery, to assist the surgeon in locating anatomical structures in open or minimally invasive procedures. The same record describes the RIVA Posterior Fixation System as intended to provide immobilization and stabilization of spinal segments in skeletally mature patients, with the remainder of that statement not captured in the public information. [7][8]
Product components as published
Xenix Medical's own RIVA product page describes a modular fixation system in which tulips and shanks snap together with audible and tactile feedback, allowing intraoperative adjustment and interchange. The page lists screw options including cortical cancellous or dual lead, solid, fenestrated or cannulated, diameters from 4.5mm to 12.5mm and lengths from 25mm to 110mm, plus head styles such as standard, reduction, closed top, double head and favored angle variants, and rod-to-rod and lateral connectors. [3]
The company’s technology page describes NANOACTIV as a proprietary implant surface engineered with nano-scale features. It describes the neoWave matrix as a repeating waveform structure without a solid framework, with edge-to-edge porosity. The page notes that in vitro performance may not be representative of clinical performance. These are the manufacturer’s material and design descriptions. [6]
Portfolio context and limits
The supplied collection contains one linked 510(k) record, K262193, and its decision count is one SESE; the record sample is the same single entry, so the sample decision count is also one SESE. These figures describe the supplied filings as of November 20, 2026 and are not measures of total company sales, total portfolio or safety performance. No recall records appear in the supplied sample. [1]
The company's home page lists LUX Expandable Interbody System, RIVA Posterior Fixation System, SOLACE Sacroiliac, neoWave C and neoWave LS among products, and neoWave and NANOACTIV among technologies, and states ISO 13485:2016 certification by NQA. Those statements are the publisher's own; independent verification, ownership structure beyond the HT Medical d.b.a. Xenix Medical designation, headquarters and commercial availability are not established by the public documents. [5]


